Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis
Qiao Ke,
Lei Wang,
Ziguo Lin,
Hongzhi Liu,
Jianying Lou,
Shuguo Zheng,
Xinyu Bi,
Jianming Wang,
Wei Guo,
Fuyu Li,
Jian Wang,
Yamin Zheng,
Jingdong Li,
Shi Cheng,
Weiping Zhou,
Jingfeng Liu,
Yongyi Zeng
Affiliations
Qiao Ke
Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University
Lei Wang
Department of Oncology, the Second Affiliated Hospital of Nanchang University
Ziguo Lin
Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University
Hongzhi Liu
Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University
Jianying Lou
Department of Hepatobiliary Surgery, the Second Hospital Affiliated to Zhejiang University
Shuguo Zheng
Department of Hepatobiliary Surgery, the Southwest Hospital Affiliated to the Army Medical University
Xinyu Bi
Department of Hepatobiliary Surgery, Cancer Hospital, Chinese Academy of Medical Sciences
Jianming Wang
Department of Hepatobiliary Surgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science &Technology
Wei Guo
Department of Hepatobiliary Surgery, Beijing Friendship Hospital Affiliated to Capital Medical University
Fuyu Li
Department of Hepatobiliary Surgery, the West China Hospital of Sichuan University
Jian Wang
Department of Hepatobiliary Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University
Yamin Zheng
Department of Hepatobiliary Surgery, Xuanwu Hospital Affiliated to Capital Medical University
Jingdong Li
Department of Hepatobiliary Surgery, the Affiliated Hospital of Chuanbei Medical University
Shi Cheng
Department of Hepatobiliary Surgery, Tiantan Hospital Affiliated to Capital Medical University
Weiping Zhou
Department of Hepatobiliary Surgery III, Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Jingfeng Liu
Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University
Yongyi Zeng
Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University
Abstract Background Radical resection is still the most cost-effectiveness curative strategy for intrahepatic cholangiocarcinoma (ICC), but it remains controversial on the survival benefit of anatomic resection (AR). In this study, we sought to compare the oncologic outcomes between AR versus non-AR (NAR) as the primary treatment for early-stage ICC patients. Methods Data of ICC patients who underwent hepatectomy and staged at AJCC I were retrospectively collected from 12 hepatobiliary centers in China between Dec 2012 and Dec 2015. Propensity score matching (PSM) and stabilized inverse probability of treatment weighting (IPTW) analysis were performed to minimize the effect of potential confounders, and the perioperative and long-term outcomes between AR and NAR groups were compared. Results Two hundred seventy-eight ICC patients staged at AJCC I were eligible for this study, including 126 patients receiving AR and 152 patients receiving NAR. Compared to the NAR group, the AR group experienced more intraoperative blood loss before and after PSM or stabilized IPTW (all P > 0.05); AR group also experienced more intraoperative transfusion after stabilized IPTW (P > 0.05). In terms of disease-free survival (DFS) and overall survival (OS), no significant differences were observed between the two groups before and after PSM or stabilized IPTW (all P > 0.05). Multivariable Cox regression analyses found that AR was not an independent prognostic factor for either DFS or OS (all P > 0.05). Further analysis also showed that the survival benefit of AR was not found in any subgroup stratified by Child–Pugh grade (A or B), cirrhosis (presence or absence), tumor diameter (≤ 5 cm or > 5 cm) and pathological type (mass-forming or non-mass-forming) with all P > 0.05. Conclusion Surgical approach does not influence the prognosis of patients with stage I primary ICC, and NAR might be acceptable and oncological safety.